Director - Commissioning and Qualification at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Bachelor’s degree in engineering, related science or Project Management, or a related field
  • Minimum of 10 years of experience in commissioning and qualification activities within the pharmaceutical or biotech industry
  • Preferred Qualifications
  • Proven track record of managing large-scale C&Q programs from design phase through to closeout and handover
  • Strong knowledge of ASTM E2500 Model and Verification methodology
  • Excellent leadership, communication, and organizational skills
  • Ability to work effectively in a cross-functional team environment
  • Experience with major site projects and pharmaceutical & process safety processes
  • Familiarity with regulatory requirements and industry standards for commissioning and qualification
  • Certification in project management (PMP or equivalent) is a plus

Responsibilities

  • Lead the development of effective global safety programs from procedure development, delivery training and coaching to transfer the knowledge to the project CQV leader for execution in the field during project
  • Develop and ensure implementation of comprehensive C&Q strategies for major capital projects, including parallel commissioning of multiple production facilities and support buildings in a GMP and process safety regulated environment
  • Create guidance that will transfer to the project C&Q lead to managing the development of CQ strategies and execution plans, schedule, and budget to ensure timely and cost-effective delivery
  • Provide technical oversight and guidance to the C&Q team, ensuring adherence to industry standards and best practices
  • Coordinate with project C&Q Leaders and teams to assess, provide direction, and oversee the implementation of engineering and construction services
  • Ensure guidance for the development and maintaining traceability matrices to demonstrate how commissioning testing met user requirements
  • Develop guidance and work hand-to-hand with project C&Q organization to support schedule and deliver to budget in collaboration with the Process Equipment COE and other key professional services to maintain a diverse and capable pool of service providers
  • Monitor and understand market conditions to educate and influence project decisions with current data

Skills

Commissioning
Qualification
CQV
GMP
Process Safety
Regulatory Compliance
Project Management
Safety Programs
Procedure Development
Training
Coaching
Technical Oversight

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI